{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:07:44Z","timestamp":1790204864360,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.sapharm.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T17:05:16Z","timestamp":1776013516000},"page":"793-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An international scoping review of opioid-related stigma interventions within the pharmacy profession"],"prefix":"10.1016","volume":"22","author":[{"given":"Darcy","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Towle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derna","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Radley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1422-9415","authenticated-orcid":false,"given":"Natalie","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2026.04.002_bib1","author":"SeeMe"},{"key":"10.1016\/j.sapharm.2026.04.002_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.soc.27.1.363","article-title":"Conceptualizing Stigma","volume":"27","author":"Link","year":"2001","journal-title":"Annu Rev Sociol"},{"issue":"7","key":"10.1016\/j.sapharm.2026.04.002_bib3","article-title":"An investigation of stigma in individuals receiving treatment for substance abuse","volume":"32","author":"Luoma","year":"2007","journal-title":"J Addict Behav"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1250-8","article-title":"A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries","volume":"17","author":"Kane","year":"2019","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.sapharm.2026.04.002_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/014107680209500205","article-title":"Stigma in psychiatry","volume":"95","author":"Gray","year":"2002","journal-title":"J R Soc Med"},{"key":"10.1016\/j.sapharm.2026.04.002_bib6","author":"Singleton"},{"issue":"12","key":"10.1016\/j.sapharm.2026.04.002_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-020-01342-8","article-title":"Spread the word: there are two opioid crises","volume":"80","author":"Marchetti Cal\u00f4nego","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/00027162231155040","article-title":"Loss of life and labor productivity: the Canadian opioid crisis","volume":"703","author":"Cheung","year":"2022","journal-title":"Ann Am Acad Pol Soc Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib9","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2021.2219","article-title":"Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018","volume":"64","author":"Pierce","year":"2021","journal-title":"Eur Psychiatry"},{"issue":"6","key":"10.1016\/j.sapharm.2026.04.002_bib10","doi-asserted-by":"crossref","DOI":"10.24095\/hpcdp.38.6.02","article-title":"The opioid crisis in Canada: a national perspective","volume":"38","author":"Belzak","year":"2018","journal-title":"Health Promot Chronic Dis Prev Can"},{"issue":"10324","key":"10.1016\/j.sapharm.2026.04.002_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02252-2","article-title":"Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission","volume":"399","author":"Humphreys","year":"2022","journal-title":"Lancet"},{"issue":"438","key":"10.1016\/j.sapharm.2026.04.002_bib12","article-title":"U.S.) CfDCaP. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic","volume":"438","year":"2020","journal-title":"HAN"},{"key":"10.1016\/j.sapharm.2026.04.002_bib14","series-title":"Opioid- and stimulant-related Harms in Canada","year":"2025"},{"issue":"6","key":"10.1016\/j.sapharm.2026.04.002_bib15","doi-asserted-by":"crossref","DOI":"10.3109\/14659890802695840","article-title":"Experiences, attitudes and training needs of pharmacy support staff providing services to drug users in Great Britain: a qualitative study","volume":"14","author":"Mackridge","year":"2009","journal-title":"J Subst Use"},{"key":"10.1016\/j.sapharm.2026.04.002_bib16","series-title":"Care DoHaS","article-title":"Opioid substitution treatment: guide for keyworkers","year":"2021"},{"key":"10.1016\/j.sapharm.2026.04.002_bib17","article-title":"Pharmacies and opioid dependency: working together to better support recovery the Pharmaceutical","author":"Britton","year":"2022","journal-title":"Journal"},{"key":"10.1016\/j.sapharm.2026.04.002_bib18","author":"Sheen"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-1-3","article-title":"Substance abuse and pharmacy practice: what the community pharmacist needs to know about drug abuse and dependence","volume":"1","author":"Tommasello","year":"2004","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.sapharm.2026.04.002_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104212","article-title":"Substance use and common contributors to morbidity: a genetics perspective","author":"Sanchez-Roige","year":"2022","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.002_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/pubmed\/fdw138","article-title":"\u2018Standing Outside the Junkie Door\u2019\u2014service users' experiences of using community pharmacies to access treatment for opioid dependency","volume":"39","author":"Radley","year":"2016","journal-title":"J Public Health"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/add.70180","article-title":"Professionalism, professional identity and community pharmacy culture: the context of substance dependency through the lens of student and early career pharmacists","volume":"121","author":"Weir","year":"2026","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.sapharm.2026.04.002_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/16066359.2021.1875215","article-title":"Changing the narrative: a call to end stigmatizing terminology related to substance use disorders","volume":"29","author":"Atayde","year":"2021","journal-title":"Addict Res Theory"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/17151635211063188","article-title":"Overcoming stigma in pharmacy practice","volume":"155","author":"Gysel","year":"2022","journal-title":"Can Pharm J"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib25","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.sapharm.2026.04.002_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jphs.12374","article-title":"The pharmacists' contribution against opioid addiction","volume":"11","author":"Wertheimer","year":"2020","journal-title":"J Pharm Health Serv Res"},{"key":"10.1016\/j.sapharm.2026.04.002_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.drugpo.2018.06.015","article-title":"Stigma and the public health agenda for the opioid crisis in America","volume":"59","author":"Corrigan","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.sapharm.2026.04.002_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/15291006231198193","article-title":"Stigma toward substance dependence: causes, consequences, and potential interventions","volume":"24","author":"Krendl","year":"2023","journal-title":"Psychol Sci Public Interest [Internet]"},{"issue":"9","key":"10.1016\/j.sapharm.2026.04.002_bib29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1046\/j.1360-0443.1999.94913497.x","article-title":"Attitudinal factors associated with community pharmacists' involvement in services for drug misusers","volume":"94","author":"Matheson","year":"1999","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.002_bib30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s40596-014-0067-1","article-title":"Reducing Stigma towards substance users through an educational intervention: harder than it looks","volume":"38","author":"Crapanzano","year":"2014","journal-title":"Acad Psychiatry"},{"key":"10.1016\/j.sapharm.2026.04.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108486","article-title":"A systematic review of stigma interventions for providers who treat patients with substance use disorders","author":"Bielenberg","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"issue":"7","key":"10.1016\/j.sapharm.2026.04.002_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.sapharm.2026.04.002_bib35","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev [Internet]"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib36","article-title":"Longitudinal evaluation of pharmacists' social distance preference and attitudes toward patients with opioid misuse following an educational training program","volume":"43","author":"Werremeyer","year":"2022","journal-title":"Substance Abuse [Internet]"},{"issue":"2","key":"10.1016\/j.sapharm.2026.04.002_bib37","article-title":"Evaluating attitudes among healthcare graduate students following interprofessional education on opioid use disorder","volume":"124","author":"Karagiannis","year":"2024","journal-title":"J Osteopath Med [Internet]"},{"issue":"5","key":"10.1016\/j.sapharm.2026.04.002_bib38","article-title":"\u201cI go out of my way to give them an extra smile now:\u201d A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials","volume":"20","author":"Irwin","year":"2024","journal-title":"Res Social Adm Pharm [Internet]"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib39","article-title":"Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician","volume":"63","author":"Irwin","year":"2023","journal-title":"J Am Pharm Assoc [Internet]"},{"issue":"3","key":"10.1016\/j.sapharm.2026.04.002_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2019.11.030","article-title":"Impact of the RESPOND toolkit on community pharmacists' opioid safety attitudes, self-efficacy, and knowledge","volume":"60","author":"Irwin","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.002_bib41","article-title":"Community impact of pharmacy-randomized intervention to improve access to syringes and services for injection drug users","volume":"41","author":"Crawford","year":"2014","journal-title":"Health Educ Behav [Internet]"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib42","article-title":"Promoting harm reduction in rural South Dakota using an interdisciplinary consortium","volume":"63","author":"Miller","year":"2023","journal-title":"JAPhA Pract Innov [Internet]"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib43","article-title":"An implementation-focused qualitative exploration of pharmacist needs regarding an opioid use disorder screening and brief intervention","volume":"45","author":"Rao","year":"2024","journal-title":"Subst Use Addctn J [Internet]"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.002_bib44","article-title":"Project lifeline: implementing SBIRT in rural pharmacies to address opioid overdoses and substance use disorder","volume":"49","author":"Cloutier","year":"2023","journal-title":"Am J Drug Alcohol Abuse [Internet]"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.002_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/ajhp\/zxaa387","article-title":"Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order","volume":"78","author":"Santa","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sapharm.2026.04.002_bib46","article-title":"An intervention pilot to facilitate harm reduction service decentralization in Vietnam","volume":"144","author":"Lin","year":"2023","journal-title":"J Subst Abuse Treat [Internet]"},{"issue":"7","key":"10.1016\/j.sapharm.2026.04.002_bib47","article-title":"Evaluation of online training for the provision of opioid substitution treatment by community pharmacists in New Zealand","volume":"31","author":"Walters","year":"2012","journal-title":"Drug Alcohol Rev [Internet]"},{"issue":"5","key":"10.1016\/j.sapharm.2026.04.002_bib48","first-page":"576","article-title":"Professional education to reduce provider stigma toward harm reduction and pharmacotherapy","volume":"29","author":"Sulzer","year":"2022","journal-title":"Drugs [Internet]"},{"key":"10.1016\/j.sapharm.2026.04.002_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmqr.2022.100161","article-title":"Variation in intervention stigma among medications for opioid use disorder","author":"Madden","year":"2022","journal-title":"SSM Qual Res Health [Internet]"},{"issue":"2","key":"10.1016\/j.sapharm.2026.04.002_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2021.10.002","article-title":"Ensuring buprenorphine access in rural community pharmacies to prevent overdoses","volume":"62","author":"Ostrach","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.sapharm.2026.04.002_bib51","article-title":"\u201cYou\u2019re not supposed to be on it forever\u201d: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids","author":"Dickson-Gomez","year":"2022","journal-title":"Subst Abuse: Research and Treatment [Internet]"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib52","article-title":"Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies","volume":"19","author":"Rao","year":"2024","journal-title":"Addict Sci Clin Pract [Internet]"},{"issue":"2","key":"10.1016\/j.sapharm.2026.04.002_bib53","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/10401334.2020.1820869","article-title":"Using contact-based education to destigmatize opioid use disorder among medical students","volume":"33","author":"Mort","year":"2021","journal-title":"Teach Learn Med"},{"issue":"12","key":"10.1016\/j.sapharm.2026.04.002_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.cptl.2022.10.002","article-title":"Contact based intervention reduces stigma among pharmacy students","volume":"14","author":"Bakos-Block","year":"2022","journal-title":"Curr Pharm Teach Learn"},{"issue":"2","key":"10.1016\/j.sapharm.2026.04.002_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40596-024-01945-3","article-title":"Evaluation of two videos that apply evidence-based strategies to increase self-efficacy and reduce opioid-related stigma among medical students","volume":"48","author":"Eschliman","year":"2024","journal-title":"Acad Psychiatry"},{"issue":"6","key":"10.1016\/j.sapharm.2026.04.002_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy10060161","article-title":"Podcasts as a method to deliver education on stigma surrounding opioid use disorder","volume":"10","author":"Kissell","year":"2022","journal-title":"Pharmacy"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.002_bib57","article-title":"Adapting the opening minds stigma Scale for healthcare providers to measure opioid-related stigma","volume":"12","author":"Cid","year":"2024","journal-title":"BMC Psychiatry [Internet]"},{"issue":"5","key":"10.1016\/j.sapharm.2026.04.002_bib59","article-title":"The effect of educational intervention on pharmacists' attitudes to substance misusers","volume":"10","author":"Jones","year":"2005","journal-title":"J Subst Use Addict Treat [Internet]"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.002_bib60","article-title":"A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians","volume":"18","author":"Hooker","year":"2023","journal-title":"Addict Sci Clin Pract [Internet]"},{"key":"10.1016\/j.sapharm.2026.04.002_bib61","doi-asserted-by":"crossref","first-page":"100611","DOI":"10.1016\/j.lanepe.2023.100611","article-title":"An acceptance-based, intersectional stigma coping intervention for people with HIV who inject drugs-a randomized clinical trial","volume":"28","author":"Luoma","year":"2023","journal-title":"Lancet Reg Health Eur [Internet]"},{"issue":"12","key":"10.1016\/j.sapharm.2026.04.002_bib62","doi-asserted-by":"crossref","DOI":"10.12788\/jhm.3256","article-title":"Opioid utilization and perception of pain control in hospitalized patients: a cross-sectional Study of 11 sites in 8 countries","volume":"14","author":"Burden","year":"2019","journal-title":"J Hosp Med"},{"issue":"3","key":"10.1016\/j.sapharm.2026.04.002_bib63","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11606-020-05974-0","article-title":"Societal biases, institutional discrimination, and trends in opioid use in the USA","volume":"36","author":"Fine","year":"2021","journal-title":"J Gen Intern Med"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126000823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126000823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:55:18Z","timestamp":1780044918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741126000823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1551741126000823"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.04.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An international scoping review of opioid-related stigma interventions within the pharmacy profession","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}